Shape-shifting cells rush to repair the defect after bone injury

Shape-shifting cells rush to repair the defect after bone injury

Specific gut microbes have the capacity to affect normal skeletal growth and maturation Bone fracture is an emergency for humans and all vertebrates, so the sooner cells start the business of healing damaged bone-;and the more cells there are to do it-;the better. "Our study shows that other cells besides skeletal stem cells can do this job as well," Ono said. In the mouse study, inert Cxcl12 cells in bone marrow responded to post-injury cellular cues by converting into regenerative cells, much like skeletal stem cells. Normally, the main job of these Cxcl12-expressing cells, widely known as CAR cells, is to secrete cytokines, which help regulate neighboring blood cells. They were recruited for healing only after an injury. The surprise in our study is that these cells essentially did nothing in terms of making bones, when bones grow longer. It's only when bones are injured that these cells start rushing to repair the defect." Noriaki Ono, assistant professor at the U-M School of Dentistry This is important because the remarkable regenerative potential of bones is generally attributed to rare skeletal stem cells, Ono says. These new findings raise the possibility that these mighty skeletal stem cells could be generated through the transformation of the more available mature stromal cells. These mature stromal cells are malleable and readily available throughout life, and could potentially provide an excellent cellular source for bone and tissue regeneration, Ono says. Source: University of Michigan Journal reference: Matsushita, Y., et al. (2020) A Wnt-mediated transformation of the bone marrow stromal cell identity orchestrates skeletal regeneration. Nature Communications . doi.org/10.1038/s41467-019-14029-w .



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More